Lixin Sun

Dr. Lixin Sun


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Fitoterapia
Verified
Journal Article
Closed access
GWGuanghou Wang
Guanghou Wang
LHLijuan Hou
Lijuan Hou
YWYue Wang
Yue Wang
HLHuan Liu
Huan Liu
JYJiu-zhi Yuan
Jiu-zhi Yuan
LSLixin Sun
Lixin Sun

10 June 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XSXiaomeng Sun
Xiaomeng Sun
LALun Ai
Lun Ai
YRYinfei Ran
Yinfei Ran
YZYiwen Zhang
Yiwen Zhang
QZQian Zhang
Qian Zhang
LSLixin Sun
Lixin Sun
Sang Xing decoction (SXD) is a typical prescription for treating "warm dryness" in traditional Chinese medicine (TCM), which is equivalent to respiratory diseases such as acute bronchitis in modern medicine. However, its mechanism of action remains unclear. In this study, the representative components of SXD were characterized using liquid chromatography-tandem mass spectrometry (LC-MS). The key targets, signaling pathways, and metabolic pathways associated with SXD in the treatment of acute bronchitis were identified via network prediction and metabolomics. A rat model of acute bronchitis was also established using mixed smoke, systematic in vivo experiments such as histopathological analyses, enzyme-linked immunosorbent assay (ELISA), immunofluorescence, immunohistochemistry and western blotting were conducted to evaluate the network prediction results. An in-depth analysis of the targeted quantitative results was performed using the SIMCA software and MetaboAnalyst website. The results revealed that 50 active compounds and 45 key targets were screened and clustered with 20 approved drugs. The NF-κB signaling pathway, oxidative stress, and glutamine metabolism were associated with the therapeutic mechanism of SXD in acute bronchitis. In vivo experiments showed that SXD may maintain the production of inflammatory factors by regulating the PI3K/Akt/NF-κB signaling pathway, improving the metabolism of glutamine and glutamate to reduce oxidative stress, and inhibiting apoptosis. Simultaneously, the possibility of using SXD as an adjuvant drug for COVID-19 treatment was also revealed. This research will lay the foundation for the modern clinical application of SXD and promote the promotion and innovation of TCM.

22 May 2024 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
JWJiayue Wang
Jiayue Wang
FQFeixu Qin
Feixu Qin
HWHongjin Wang
Hongjin Wang
LWLu Wang
Lu Wang
CLCaihong Li
Caihong Li
LSLixin Sun
Lixin Sun

1 August 2023 in Journal of Separation Science
Verified
Journal Article
Closed access
TZTao Zhen
Tao Zhen
HWHongjin Wang
Hongjin Wang
CLCaihong Li
Caihong Li
HBHuafang Bai
Huafang Bai
FQFeixu Qin
Feixu Qin
LSLixin Sun
Lixin Sun

12 June 2024 in Journal of Chromatography B
Verified
Journal Article
Closed access
XMXiangping Meng
Xiangping Meng
CLCaihong Li
Caihong Li
AGAichun Gao
Aichun Gao
HWHongjin Wang
Hongjin Wang
LWLan Wei
Lan Wei
LSLixin Sun
Lixin Sun

9 May 2024 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
HZHao Zhang
Hao Zhang
HWHongjin Wang
Hongjin Wang
XGXiang Gao
Xiang Gao
GWGuanghou Wang
Guanghou Wang
LSLixin Sun
Lixin Sun